Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
SEC Accession No. 0001193125-09-076530
Filing Date
2009-04-09
Accepted
2009-04-09 16:11:27
Documents
3
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM 10-K d10ka.htm 10-K/A 50053
2 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER dex311.htm EX-31.1 9434
3 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER dex312.htm EX-31.2 9421
  Complete submission text file 0001193125-09-076530.txt   70308
Mailing Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043
Business Address 2400 BAYSHORE PARKWAY, SUITE 200 MOUNTAIN VIEW CA 94043 650-386-3100
MAP Pharmaceuticals, Inc. (Filer) CIK: 0001401923 (see all company filings)

EIN.: 200507047 | State of Incorp.: DE
Type: 10-K/A | Act: 34 | File No.: 001-33719 | Film No.: 09742912
SIC: 2834 Pharmaceutical Preparations